A recent study reveals a significant decrease in plasma Netrin-1 levels with a positive correlation with UPDRS (Unified Parkinson’s Disease Rating Scale) scores in PD patients (Hua et al., 2023), strongly supporting its biomarker potential in this second most common neurodegenerative disease. Here, NTN1 is linked to neurodegenerative disease.